Madlen B. Labib

628 total citations
17 papers, 530 citations indexed

About

Madlen B. Labib is a scholar working on Organic Chemistry, Pharmacology and Molecular Biology. According to data from OpenAlex, Madlen B. Labib has authored 17 papers receiving a total of 530 indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Organic Chemistry, 10 papers in Pharmacology and 2 papers in Molecular Biology. Recurrent topics in Madlen B. Labib's work include Synthesis and biological activity (17 papers), Inflammatory mediators and NSAID effects (10 papers) and Synthesis of heterocyclic compounds (3 papers). Madlen B. Labib is often cited by papers focused on Synthesis and biological activity (17 papers), Inflammatory mediators and NSAID effects (10 papers) and Synthesis of heterocyclic compounds (3 papers). Madlen B. Labib collaborates with scholars based in Egypt, Saudi Arabia and United Arab Emirates. Madlen B. Labib's co-authors include Mohamed A. Abdelgawad, Khaled R.A. Abdellatif, Phoebe F. Lamie, Mahmoud Abdel‐Latif, El‐Shaymaa El‐Nahass, John N. Philoppes, Eman K. A. Abdelall, Gehan M. Kamel, Amany A. Azouz and Mahmoud El‐Daly and has published in prestigious journals such as Bioorganic & Medicinal Chemistry Letters, Journal of Molecular Structure and Chemical and Pharmaceutical Bulletin.

In The Last Decade

Madlen B. Labib

16 papers receiving 522 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Madlen B. Labib Egypt	13	445	174	100	62	49	17	530
Afaf El‐Malah Egypt	14	308 0.7×	105 0.6×	145 1.4×	45 0.7×	41 0.8×	27	434
Phoebe F. Lamie Egypt	18	712 1.6×	214 1.2×	201 2.0×	127 2.0×	68 1.4×	33	875
Adrián Puerta Spain	13	326 0.7×	74 0.4×	181 1.8×	36 0.6×	55 1.1×	46	479
Salah A. Abdel‐Aziz Egypt	14	440 1.0×	77 0.4×	269 2.7×	51 0.8×	86 1.8×	35	653
A. A. B. HAZZAA Egypt	12	461 1.0×	97 0.6×	137 1.4×	35 0.6×	28 0.6×	29	560
John N. Philoppes Egypt	12	326 0.7×	67 0.4×	94 0.9×	68 1.1×	51 1.0×	16	408
Ehab M. Gedawy Egypt	14	405 0.9×	87 0.5×	303 3.0×	43 0.7×	89 1.8×	29	640
Yasmine M. Abdel Aziz Egypt	12	296 0.7×	47 0.3×	127 1.3×	36 0.6×	62 1.3×	19	394
Mukund P. Tantak India	14	334 0.8×	62 0.4×	172 1.7×	27 0.4×	26 0.5×	24	440
Dong Cao China	11	424 1.0×	69 0.4×	285 2.9×	30 0.5×	96 2.0×	20	622

Countries citing papers authored by Madlen B. Labib

Since Specialization

Citations

This map shows the geographic impact of Madlen B. Labib's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Madlen B. Labib with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Madlen B. Labib more than expected).

Fields of papers citing papers by Madlen B. Labib

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Madlen B. Labib. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Madlen B. Labib. The network helps show where Madlen B. Labib may publish in the future.

Co-authorship network of co-authors of Madlen B. Labib

This figure shows the co-authorship network connecting the top 25 collaborators of Madlen B. Labib. A scholar is included among the top collaborators of Madlen B. Labib based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Madlen B. Labib. Madlen B. Labib is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

17 of 17 papers shown

Abdelall, Eman K. A., et al.. (2025). Synthesis of new selective agents with dual anti-inflammatory and SARS-CoV-2 Mpro inhibitory activity: Antipyrine-celecoxib hybrid analogues; COX-2, COVID-19 cytokine storm and replication inhibitory activities.. Bioorganic Chemistry. 160. 108429–108429.

Abdelall, Eman K. A., et al.. (2023). Design, synthesis of novel chromene‐based scaffolds targeting hepatocellular carcinoma: Cell cycle arrest, cytotoxic effect against resistant cancer cells, apoptosis induction, and c‐Src inhibition. Drug Development Research. 85(1). e22133–e22133. 4 indexed citations

Labib, Madlen B., et al.. (2022). Novel pyrazole-based COX-2 inhibitors as potential anticancer agents: Design, synthesis, cytotoxic effect against resistant cancer cells, cell cycle arrest, apoptosis induction and dual EGFR/Topo-1 inhibition. Bioorganic Chemistry. 131. 106273–106273. 32 indexed citations

Abdellatif, Khaled R.A., et al.. (2022). Novel pyrazole-oxadiazole hybrids possessing methanesulphonyl pharmacophore with good gastric safety profile: Design, synthesis, cyclooxygenase inhibition, anti-inflammatory activity and histopathological studies. Journal of Molecular Structure. 1266. 133529–133529. 3 indexed citations

Abdellatif, Khaled R.A., et al.. (2020). Synthesis of novel halogenated triarylpyrazoles as selective COX-2 inhibitors: Anti-inflammatory activity, histopatholgical profile and in-silico studies. Bioorganic Chemistry. 105. 104418–104418. 27 indexed citations

Labib, Madlen B., et al.. (2020). Novel tetrazole-based selective COX-2 inhibitors: Design, synthesis, anti-inflammatory activity, evaluation of PGE2, TNF-α, IL-6 and histopathological study. Bioorganic Chemistry. 104. 104308–104308. 39 indexed citations

Abdellatif, Khaled R.A., et al.. (2019). New pyrazole derivatives possessing amino/methanesulphonyl pharmacophore with good gastric safety profile: Design, synthesis, cyclooxygenase inhibition, anti-inflammatory activity and histopathological studies. Bioorganic Chemistry. 95. 103540–103540. 38 indexed citations

Abdellatif, Khaled R.A., et al.. (2019). Design, synthesis of celecoxib-tolmetin drug hybrids as selective and potent COX-2 inhibitors. Bioorganic Chemistry. 90. 103029–103029. 19 indexed citations

Labib, Madlen B., et al.. (2018). Design, synthesis of novel isoindoline hybrids as COX-2 inhibitors: Anti-inflammatory, analgesic activities and docking study. Bioorganic Chemistry. 80. 70–80. 37 indexed citations

10.

Abdelgawad, Mohamed A., et al.. (2018). Design, synthesis, analgesic, anti-inflammatory activity of novel pyrazolones possessing aminosulfonyl pharmacophore as inhibitors of COX-2/5-LOX enzymes: Histopathological and docking studies. Bioorganic Chemistry. 78. 103–114. 79 indexed citations

11.

Labib, Madlen B., et al.. (2018). Design, synthesis, and screening of ortho-amino thiophene carboxamide derivatives on hepatocellular carcinomaas VEGFR-2Inhibitors. Journal of Enzyme Inhibition and Medicinal Chemistry. 33(1). 1472–1493. 27 indexed citations

12.

Abdellatif, Khaled R.A., et al.. (2017). Synthesis and Biological Evaluation of New Diarylpyrazole and Triarylimidazoline Derivatives as Selective COX‐2 Inhibitors. Archiv der Pharmazie. 350(8). 26 indexed citations

13.

Labib, Madlen B., et al.. (2017). Azole-hydrazone derivatives: Design, synthesis, in vitro biological evaluation, dual EGFR/HER2 inhibitory activity, cell cycle analysis and molecular docking study as anticancer agents. Bioorganic Chemistry. 76. 67–80. 71 indexed citations

14.

Abdelgawad, Mohamed A., Madlen B. Labib, & Mahmoud Abdel‐Latif. (2017). Pyrazole-hydrazone derivatives as anti-inflammatory agents: Design, synthesis, biological evaluation, COX-1,2/5-LOX inhibition and docking study. Bioorganic Chemistry. 74. 212–220. 73 indexed citations

15.

Labib, Madlen B. & Phoebe F. Lamie. (2016). Design, synthesis and biological evaluation of novel thiophene and theinopyrimidine derivatives as anticancer agents. Medicinal Chemistry Research. 25(11). 2607–2618. 8 indexed citations

16.

Abdellatif, Khaled R.A., et al.. (2015). Synthesis, cyclooxygenase inhibition, anti-inflammatory evaluation and ulcerogenic liability of novel triarylpyrazoline derivatives as selective COX-2 inhibitors. Bioorganic & Medicinal Chemistry Letters. 25(24). 5787–5791. 31 indexed citations

17.

Kandeel, Manal M., et al.. (2013). Synthesis of Some Novel Thieno[3,2-<i>d</i>]pyrimidines as Potential Cytotoxic Small Molecules against Breast Cancer. Chemical and Pharmaceutical Bulletin. 61(6). 637–647. 16 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact